Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;226(2):261-262.
doi: 10.1016/j.ajog.2021.10.006. Epub 2021 Oct 11.

Newborns' passive humoral SARS-CoV-2 immunity following heterologous vaccination of the mother during pregnancy

Affiliations

Newborns' passive humoral SARS-CoV-2 immunity following heterologous vaccination of the mother during pregnancy

Stefan Gloeckner et al. Am J Obstet Gynecol. 2022 Feb.
No abstract available

PubMed Disclaimer

Figures

Figure
Figure
S-IgG antibody kinetics after heterologous vaccination Stars represent values measured in cord blood at time of birth. The orange curve represents the geometric means of concentrations in the control group, the orange area shows the range between minimum and maximum values measured in the control group.

References

    1. Vygen-Bonnet S., Koch J., Bogdan C., et al. Beschluss der STIKO zur 4. Aktualisierung der COVID-19-Impfempfehlung und die dazugehörige wissenschaftliche Begründung. Epid Bull. 2021;16:3–78.
    1. Gray K.J., Bordt E.A., Atyeo C., et al. Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study. Am J Obstet Gynecol. 2021;225:303.e1–303.e17. - PMC - PubMed
    1. Kubiak J.M., Murphy E.A., Yee J., et al. Severe acute respiratory syndrome coronavirus 2 serology levels in pregnant women and their neonates. Am J Obstet Gynecol. 2021;225:73.e1–73.e7. - PMC - PubMed
    1. Mithal L.B., Otero S., Shanes E.D., Goldstein J.A., Miller E.S. Cord blood antibodies following maternal coronavirus disease 2019 vaccination during pregnancy. Am J Obstet Gynecol. 2021;225:192–194. - PMC - PubMed
    1. Liu X., Shaw R.H., Stuart A.S., et al. Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial. Lancet. 2021;398:856–869. - PMC - PubMed

Publication types

MeSH terms

Supplementary concepts